Crossmark

The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin

Crossref DOI link: https://doi.org/10.1186/s12933-018-0704-1

Published Online: 2018-04-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aroor, Annayya R.

Manrique-Acevedo, Camila

DeMarco, Vincent G. https://orcid.org/0000-0003-2092-9995
Funding

Funding for this research was provided by:

Boehringer Ingelheim
License Information

Text and Data Mining valid from 2018-04-18
More Information

Article History

Received: 15 February 2018

Accepted: 12 April 2018

First Online: 18 April 2018